首页 | 本学科首页   官方微博 | 高级检索  
检索        

血栓通联合低分子肝素钙治疗进展性缺血性脑卒中临床观察
引用本文:徐守权,劳永新.血栓通联合低分子肝素钙治疗进展性缺血性脑卒中临床观察[J].天津中医药,2014,31(4):218-219.
作者姓名:徐守权  劳永新
作者单位:梧州市中医医院内一科, 梧州 543000;广西梧州制药(集团)股份有限公司, 梧州 543002
摘    要:目的]全面分析血栓通联合低分子肝素钙方式在进展性缺血性脑卒中治疗的具体应用及临床价值。方法]选择120例进展性脑卒中患者作为本次观察对象,随机分为实验组与对照组,每组60例,两组患者均接受常规治疗,并每天注射1次生理盐水与0.3 g血栓通液体混合溶液,晚上口服0.1 g肠溶阿司匹林,实验组在此基础上每天注射两次低分子肝素。结果]对照组治愈14例,显效15例,有效19例,无效12例,总有效率为80.00%;实验组治愈21例,显效27例,有效8例,无效4例,总有效率为93.33%;两组总有效率比较差异存在统计学意义(P0.05)。结论]血栓通联合低分子肝素钙用于治疗进展性脑卒中具有较好的疗效。

关 键 词:血栓通  低分子肝素钙  联合治疗  进展性脑卒中  分析研究
收稿时间:2013/12/13 0:00:00

Clinical observation of Xueshuantong combined with low molecular heparin calciumin treating progressive ischemic stroke
XU Shou-quan and LAO Yong-xin.Clinical observation of Xueshuantong combined with low molecular heparin calciumin treating progressive ischemic stroke[J].Tianjin Journal of Traditional Chin Medicine,2014,31(4):218-219.
Authors:XU Shou-quan and LAO Yong-xin
Institution:A Section Within, The Hospital of Traditional Chinese Medicine in Wuzhou City, Wuzhou 543000, China;Guangxi Wuzhou Pharmacy Limited Liability Company, Wuzhou 543002, China
Abstract:Objective] To analyze the specific application and the clinical value of Xueshuantong combined with low molecular heparin calcium in the treatment of progressive ischemic stroke. Methods] The 120 patients with progressive stroke were served as the observation objects. They were randomly divided into control group and experimental group, receiving routine treatment first, and then injected with 0.9%NS and 0.3 g Xueshuantong liquid mixture once a day, oral 0.1g enteric coated aspirin at night. On the basis of the above treatment, in the experimental group a low molecular weight heparin was injected twice a day. Results] In the control group, 12 cases were invalid, 19 cases effective, 15 cases excellent,14 cases cured and the total effective rate was 80%; in the experimental group, 4 cases were invalid, 8 cases effective, 27 cases excellent, 21 cases cured and the total effective rate was 93.33%. There was a statistical significant difference in the total effective rate between two groups (P<0.05). Conclusion] Xueshuantong combined with low molecular weight heparin calcium has good clinical effect.
Keywords:Xueshuantong  low molecular weight heparin calcium  combined therapy  progressive stroke  analysis and research
本文献已被 CNKI 维普 等数据库收录!
点击此处可从《天津中医药》浏览原始摘要信息
点击此处可从《天津中医药》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号